Editorial Commentary: Should "heterogeneous response" be considered as new category for assessing treatment response in patients with breast cancer?
作者信息
Vaz Sofia C, Groheux David, van Nijnatten Thiemo, Antunovic Lidija, Cardoso Fatima, Mottaghy Felix, Cardoso Maria Joao, Riedl Christopher, de Geus-Oei Lioe-Fee, Ulaner Gary A
机构信息
Nuclear Medicine- Radiopharmacology, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.
Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.
出版信息
Eur J Nucl Med Mol Imaging. 2025 Feb;52(3):801-805. doi: 10.1007/s00259-024-07042-9.
PMID:39706898
Abstract
摘要
Zotero 插件